Immunovant Inc (NASDAQ:IMVT)

20.38
Delayed Data
As of Sep 22
 -0.87 / -4.09%
Today’s Change
4.26
Today|||52-Week Range
25.13
+14.82%
Year-to-Date
No recent news for Immunovant Inc.

Today’s Trading

Previous close21.25
Today’s open21.32
Day’s range20.11 - 21.51
Volume112,380
Average volume (3 months)1,170,377
Market cap$2.7B
Data as of 4:00pm ET, 09/22/2023

Growth & Valuation

Earnings growth (last year)-19.95%
Earnings growth (this year)-4.07%
Earnings growth (next 5 years)-27.70%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book7.33

Competitors

----
EXPIeXp World Holdings I...-0.03-0.18%
BURBurford Capital Ltd+0.10+0.70%
----
Data as of 4:00pm ET, 09/22/2023

Financials

Next reporting dateNovember 3, 2023
EPS forecast (this quarter)-$0.45
Annual revenue (last year)$0.00
Annual profit (last year)-$211.0M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
--, --

Forecasts